Nearly Unknown Biotech Stock Could Parabola If Pipeline Hits
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Want to turn your skills into cash? Explore ways to monetize your skills fast and increase your income.
19,311 articlesSmall, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
A major crypto development is sending ripples through the market as Ethereum reacts to optimistic signals from Iran a...
Quadrant Private Wealth recently boosted its stake in Bluerock Private Real Estate Fund by about $13.6 million. This ...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
As KB unveils its Q1 2026 results, investors will parse revenue signals, margin dynamics, and guidance. This guide br...
A routine traffic stop in North Miami set off a chain of discoveries about a $13 million crypto heist. This article b...
With SPY's yield hovering near 1% and valuations high, investors are turning to covered calls to generate cash flow. ...
As electricity demand climbs, NuScale Power presents a rare risk reward. This piece lays out one compelling buy reaso...
Big events bring big costs beyond ticketing and catering. Explore what a six-figure NYC permit can teach about budget...